JENNIFER DOAN-PHAM: Open Payments
NPI 1962179911 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,988 in 77 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,189 · 2025 $1,988
Food & beverage: $1,988
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $311 |
| Otsuka America Pharmaceutical, Inc. | 6 | $239 |
| Corium, LLC | 8 | $231 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $200 |
| Neurocrine BioSciences, Inc. | 7 | $168 |
| Janssen Pharmaceuticals, Inc | 7 | $120 |
| Teva Pharmaceuticals USA, Inc. | 4 | $119 |
| Lundbeck LLC | 5 | $114 |
| Supernus Pharmaceuticals, Inc. | 6 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $95 |
Products named: REXULTI, Auvelity, Azstarys, CAPLYTA, INGREZZA, Qelbree, TRINTELLIX, VRAYLAR.
Industry payments across TX — which companies pay providers there.
